Erythrodermic pityriasis rubra pilaris after SARS-CoV-2 vaccination with concomitant COVID-19 infection
J Eur Acad Dermatol Venereol
.
2022 Sep;36(9):e675-e676.
doi: 10.1111/jdv.18214.
Epub 2022 May 16.
Authors
T Gambichler
1
,
C H Scheel
1
,
Y Arafat
2
,
O Kautz
3
,
S Boms
2
Affiliations
1
Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
2
Department of Dermatology, Christian Hospital Unna, Unna, Germany.
3
NordWestHisto, Westerstede, Germany.
PMID:
35536694
PMCID:
PMC9347623
DOI:
10.1111/jdv.18214
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Pityriasis Rubra Pilaris* / complications
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines